Pasar al contenido principal

MODULACION DE LA INFLAMACION, APOPTOSIS Y AUTOFAGIA EN LA NEUROPROTECCION RETINIANA. INFLUENCIA DE LA VARIANTE P.ARG72PRO DEL GEN TP53

PID2023-147958OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE VALLADOLID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Retinal Organoids: Innovative Tools for Understanding Retinal Degeneration

  • Galindo-Cabello, Nadia
  • Caballano-Infantes, Estefanía
  • Benites, Gregorio
  • Pastor-Idoate, Salvador
  • Díaz-Corrales, Francisco J.
  • Usategui-Martín, Ricardo
Retinal degenerative diseases (RDDs) comprise diverse genetic and phenotypic conditions that cause progressive retinal dysfunction and cell loss, leading to vision impairment or blindness. Most RDDs lack appropriate animal models for their study, which affects understanding their disease mechanisms and delays the progress of new treatment development. Recent advances in stem cell engineering, omics, and organoid technology are facilitating research into diseases for which there are no previously existing models. The development of retinal organoids produced from human stem cells has impacted the study of retinal development as well as the development of in vitro models of diseases, opening possibilities for applications in regenerative medicine, drug discovery, and precision medicine. In this review, we recapitulate research in the retinal organoid models for RDD, mentioning some of the main pathways underlying retinal neurodegeneration that can be studied in these new models, as well as their limitations and future challenges in this rapidly advancing field., This research was funded by the Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (grants: DTS21/00086 to F.J.D.-C.), MICIU/AEI (grants: PID2023-147958OB-I00 and PDC2023-145857-100 to S.P.-I and R.U.-M.), and the Instituto de Salud Carlos III (grants: RD21/0002/0017 and RD24/0007/0008 to S.P.-I.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The TP53 Arg72Pro polymorphism predicts visual and neurodegenerative outcomes in retinal detachment

  • Galindo-Cabello, Nadia
  • Sobas-Abad, Eva M.
  • Lapresa, Rebeca
  • Agulla, Jesús
  • Almeida, Angeles
  • López, Antonio
  • Pastor-Pareja, José Carlos
  • Pastor-Idoate, Salvador
  • Usategui-Martín, Ricardo
Retinal detachment (RD) separates the retina from the retinal epithelium, causing photoreceptor apoptosis and irreversible vision loss. Even with successful surgical reattachment, complete visual recovery is not guaranteed. The TP53 Arg72Pro polymorphism, implicated in apoptosis, has emerged as a potential predictor of RD outcomes. We investigated the impact of the Arg72Pro polymorphism on retinal neurodegeneration and functional recovery in patients. The underlying mechanisms were analyzed in a humanized TP53 Arg72Pro RD mouse model. In a cohort of 180 patients, carriers of the Pro allele exhibited decreased apoptotic gene expression and improved visual recovery. Complementary findings in mice revealed that the Pro variant preserved photoreceptor integrity and reduced apoptosis rates following RD. Our findings highlight the potential of this TP53 polymorphism as a biomarker for RD outcomes and a tool for tailoring therapies. This study underscores the importance of integrating genetic profiling into personalized medicine approaches to improve recovery of RD patients’ visual outcomes., We express our gratitude to the patients for their participation, to the University of Valladolid’s Animal Welfare and Research Service for their care and technical support, and to the operating room nurses from both the University Clinic Hospital of Valladolid and the IOBA Eye Institute at the University of Valladolid for assisting in blood sample collection. This study was supported by MICIU/AEI (PID2020-114585RA-I00, PID2023-147958OB-I00, and PDC2023-145857-100 to S.P.I. and R.U.M.) (as appropriate, by the European Union Next Generation EU/PRTR) and the Instituto de Salud Carlos III (RD21/0002/0017 and RD24/0007/0008 to S.P.I., PI21/00727 and RD21/0006/0005 to A.A.). Programa estratégico IOBA from Junta de Castilla y León (Spain) (CLU-2023-1-04 to S.P.I and R.U.M)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

High-Dimensional Immune Profiling of Human Retinal Detachment Samples Using Spectral Flow Cytometry: A Protocol for Intraocular Immunotyping

  • Molinero-Sicilia, Laura
  • Hierro, Alejandro G. del
  • Galindo-Cabello, Nadia
  • Redruello-Guerrero, Pablo
  • Pastor-Idoate, Salvador
  • Usategui-Martín, Ricardo
  • Bernardo, David
Retinal detachment (RD) disrupts the eye’s immune-privileged status, causing a local inflammatory response that contributes to adverse clinical outcomes, including proliferative vitreoretinopathy and suboptimal visual recovery. Comprehensive profiling of intraocular immune cells will offer mechanistic insights and support the development of personalized immunomodulatory strategies. Here, we describe a robust and standardized protocol for the collection and high-dimensional analysis of the intraocular immune infiltrate from patients undergoing RD surgery, using state-of-the-art spectral cytometry. Vitreous and retinal tissue samples were obtained during standard surgical procedures, without the need for additional invasive interventions. Our approach integrates two complementary protocols: one that enables selective isolation of immune cells by sorting for CD45+ populations, and a second one that applies a 39-color spectral cytometry panel to profile the general landscape of immune subpopulations. The panel can identify up to 62 distinct viable immune subsets per sample, along with their functional status, as it includes expression of 13 functional markers. Hence, we hereby detail sample preparation, staining, and acquisition workflow, as well as the gating strategy and essential steps necessary for reproducible immunophenotyping. Our protocol, which enables high-dimensional immune profiling from minimal biological material, provides a valuable platform for studying ocular inflammation in RD and other retinal diseases., This work was funded by the Spanish Ministry of Science (PID2023-148270OB-I00, PID2023-147958OB-I00, and PDC2023-145857-100), Instituto de Salud Carlos III (RD21/0002/0017 and RD24/0007/0008), and Junta de Castilla y León (IR2020-1-UVA01, IR2021-UVA04, GRS-2569/A/22, GSR-2744/A1/2023, GSR-2125/A2/2024, and GSR-3073/A1/2024). David Bernardo is also a member of the CSIC´s Global Health Platform (PTI Salud Global). Finally, additional support was provided by the Department of Education of the Junta de Castilla y León and FEDER Funds (Reference: CLU-2023-1-04)., Peer reviewed